Baxalta (United States)
Baxalta is a biopharmaceutical company founded on 1 July 2015 after its parent company, Baxter International, spun off biopharmaceutical division. The company began its operation with a revenue of $6 billion, and is now a subsidiary of Takeda Pharmaceutical Company. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Baxalta (United States), United States, covering academic research published from 2001 to 2023. Read More.
Open Access Percentage
53%
Total
Publications
290
Total Open
Publications
155
Total
Citations
5.5K
Open Access
Percentage
53%
Total
Publications
290
Total Open
Publications
155
Total
Citations
5.5K
Breakdown
Publisher Open
32%
Both
18%
Other Platform Open
3%
Closed
47%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 11%
16
Hybrid 55%
81
No Guarantees 34%
49
Other Platform Open
Domain 84%
52
Institution 29%
18
Other Internet 8%
5
Preprint 3%
2
Public 2%
1
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 52 |
Europe PMC | Domain | 27 |
University of California - eScholarship University of California | Institution | 7 |
Cardiff University - ORCA Online Research @Cardiff | Institution | 4 |
California Digital Library - eScholarship | Other Internet | 3 |
whiterose.ac.uk OAI-PMH Repository | Institution | 2 |
University of Oxford - Oxford University Research Archive (ORA) | Institution | 2 |
University of Bristol - Bristol Research | Institution | 2 |
University of Toronto - TSpace | Institution | 1 |
University of Southampton - ePrints Soton | Institution | 1 |